Bulgarian researchers conducted a 12-month study showing Hericium erinaceus biomass supplementation improved brain wave patterns in 57 children with high-functioning autism spectrum disorder

MIT chemists have synthesized verticillin A for the first time since its discovery in 1970, overcoming molecular complexity that stymied researchers for decades

Reported Candidozyma auris cases in Europe rose to 1,346 in 2023 across 18 countries, with several reporting regional or national spread. The fungus is highly transmissible, difficult to control, and often resistant to antifungal drugs, posing a significant challenge for hospitals. Europe’s limited surveillance and laboratory capacity leave the true scale of infections uncertain.

Too long to read? Go for the highlights below. Compass Pathways accelerates its planned commercial launch of COMP360 for treatment-resistant depression by up to a year after favourable engagement with the FDA. Phase 3 data remain the decisive hurdle, with key 9-week and 26-week readouts expected in early 2026. Despite rising losses linked to warrant liability adjustments, the company reports a strengthened cash position sufficient to operate into 2027. Regulatory momentum and

Too long to read? Go for the highlights below.  Over 480 mushroom species across 126 genera have been identified in Africa, yet...